Correo Electrónico
DNINFOA - SIA
Bibliotecas
Convocatorias
Identidad U.N.
Publicado
Programas de gestión de enfermedades en el siglo XXI
Disease management programs in the 21st century
Palabras clave:
Manejo de la enfermedad, Costo de enfermedad, Insuficiencia cardíaca, Enfermedad pulmonar obstructiva crónica, Diabetes mellitus (es)Disease Management, Cost of Illness, Heart Failure, Disease, Pulmonary, Chronic Obstructive Pulmonary Disease, Diabetes Mellitus (en)
La gestión de enfermedades inició en EE. UU. durante los años 70 y tuvo el fin de reducir la variabilidad de los procesos asistenciales y administrativos, controlar el gasto y mejorar la calidad de la atención.
En lo corrido del presente siglo, se cuenta con una documentación amplia que permite realizar un balance sobre conceptos, componentes, metodologías y retos de los programas de gestión de enfermedades. Estos programas constituyen una práctica integradora e innovadora que permite involucrar a los distintos grupos de interés en su implementación y desarrollo. Tales grupos también se relacionan con los procesos de gestión y manejo de las enfermedades crónicas.
Disease management started in the U.S. during the 1970s in order to decrease variability in clinical and managerial processes, control costs, and improve the quality of attention. Throughout the 21st century, a growing body of literature has emerged allowing the assessment of concepts, components, methodologies and challenges of management disease programs. These programs have become into a unifying and innovative practice that allows involvement and coordination of different interest groups during implementation and development phases; such groups are also related to the management processes of chronic diseases.
Descargas
Citas
Terol E, Hamby E, Minue S. Gestión de enfermedades (disease management): Una aproximación integral a la provisión de cuidados sanitarios. Medifam. 2001;11(2):7-20.
Krumholz HM, Currie PM, Riegel B, Phillips CO, Peterson ED, Smith R, et al. A Taxonomy for Disease Management: a scientific statement from the American Heart Association Disease Management Taxonomy Writing Group. Circulation. 2006;114(13):1432-45.
De Bruin SR, Heijink R, Lemmens LC, Struijs JN, Baan CA. Impact of disease management programs on healthcare expenditures for patients with diabetes, depression, heart failure or chronic obstructive pulmonary disease: A systematic review of the literature. Health Policy. 101(2):105-21.
Academy of Managed Care Pharmacy. Concept Series Paper on Disease Management; 2015.
Davidson PM, Newton PJ, Tankumpuan T, Paull G, Dennison-Himmelfarb C. Multidisciplinary Management of Chronic Heart Failure: Principles and Future Trends. Clinical Therapeutics. 2015;37(10):2225-33.
Coviello K. Disease management (health). Salem Press; 2013.
Miller TA, DiMatteo MR. Health Beliefs and Patient Adherence to Treatment. In: Friedman HS, editor. Encyclopedia of Mental Health. 2nd Ed. Oxford: Academic Press; 2016. p. 298-300.
Congressional Budget Office. An Analysis of the Literature on Disease Management Programs. Washington, D.C.: Congressional Budget Office; 2004.
Faxon DP, Schwamm LH, Pasternak RC, Peterson ED, McNeil BJ, Bufalino V, et al. Improving quality of care through disease management principles and recommendations from the American Heart Association’s Expert Panel on Disease Management. Stroke. 2004;35(6):1527-30.
McAlister FA, Lawson FM, Teo KK, Armstrong PW. A systematic review of randomized trials of disease management programs in heart failure. Am J Med. 2001;110(5):378-84.
Windham BG, Bennett RG, Gottlieb S. Care management interventions for older patients with congestive heart failure. Am J Manag Care. 2003;9(6):447-59. 12. Heart Failure Society of A. Section 8: Disease Management, Advance Directives, and End-of-Life Care in Heart Failure Education and Counseling. Journal of Cardiac Failure. 2010; 16(6):e98-e114.
Boyd KJ, Murray SA, Kendall M, Worth A, Benton TF, Clausen H. Living with advanced heart failure: a prospective, community based study of patients and their carers. Eur j Heart Fail. 2004;6(5):585-91.
Broström A, Strömberg A, Dahlström U, Fridlund B. Sleep Difficulties, Daytime Sleepiness, and Health-related Quality of Life in Patients With Chronic Heart Failure. Journal of Cardiovascular Nursing. 2004;19(4):234-42.
Clark JC, Lan VM. Heart failure patient learning needs after hospital discharge. Appl Nurs Res. 2004;17(3):150-7.
Moser DK, Watkins JF. Conceptualizing self-care in heart failure: a life course model of patient characteristics. J Cardiovasc Nurs. 2008;23(3):205-18.
Rogers AE, Addington-Hall J, Abery A, McCoy A, Bulpitt C, Coats A, et al. Knowledge and communication difficulties for patients with chronic heart failure: qualitative study. Bmj. 2000;321(7261):605-7.
The Boston Consulting Group. Realizing the Promise of disease management. Boston: BCG; 2006.
The Boston Consulting Group. Disease Management Takes Flight. Boston: BCG; 2000.
Kalem G, Turhan Ç. Mobile Technology Applications in the Healthcare Industry for Disease Management and Wellness. Procedia-Social and Behavioral Sciences. 2015;195:2014-8.
Goetzel RZ, Ozminkowski RJ, Villagra VG, Duffy J. Return on investment in disease management: a review. Health Care Financ Rev. 2005;26(4):1.
Heaney CA, Goetzel RZ. A review of health-related outcomes of multi- component worksite health promotion programs. Am J Health Promot. 1997;11(4):290-307.
Gurnee M, Da Silva R. Constructing disease management programs. Managed care. 1997;6(6):67-70, 5-6.
Annalijn E. Disease management evaluation. A comprehensive review of current state of the art. Cambridge: Westbrook Centre Milton Road; 2010.
Brook RH, Lohr KN. The definition of quality and approaches to its assessment. Health services research. 1981;16(2):236.
Educators AAoD. Standards for outcomes measurement of diabetes self-management education. The Diabetes Educator. 2003;29(5):804-16.
Steuten L, Lemmens K, Nieboer A, Vrijhoef H. Identifying potentially cost effective chronic care programs for people with COPD. Int J Chron Obstruct Pulmon Dis. 2009;4:87-100.
Pearson ML, Mattke S, Shaw R, Ridgely MS, Wiseman JSH. Patient Self-Management Support Programs: An Evaluation. Santa Monica: RAND Health. 2007.
Lorig KR, Sobel DS, Ritter PL, Laurent D, Hobbs M. Effect of a self-management program on patients with chronic disease. Eff Clin Pract. 2000;4(6):256-62.
Chodosh J, Morton SC, Mojica W, Maglione M, Suttorp MJ, Hilton L, et al. Meta-analysis: chronic disease self-management programs for older adults. Ann Intern Med. 2005;143(6):427-38.
Hussey P, Effros R. Analysis of Disease Management. Santa Mónica; 2009 [cited 2016 Dec 14]. Available from: https://goo.gl/ozEOzW.
Merrick EL, Horgan CM, Garnick DW, Hodgkin D, Morley M. Health Plans’ Disease Management Programs: Extending across the Medical and Behavioral Health Spectrum? J Ambul Care Manage. 2008;31(4):342-53.
McCall N, Cromwell J, Bernard S, editors. Evaluation of phase I of Medicare Health Support pilot program under traditional fee-for-service Medicare: 18-Month Interinm Analysis. Washington, D.C.: Report to Congress; 2008.
Brown RS, Peikes D, Chen A, Ng J, Schore J, Soh C. The evaluation of the Medicare coordinated care demonstration: Findings for the first two years. Mathematica Policy Research, Inc.; 2007.
Rijken M, Bekkema N, Boeckxstaens P, Schellevis FG, De Maeseneer JM, Groenewegen PP. Chronic Disease Management Programmes: an adequate response to patients’ needs? Health Expect. 2014;17(5):608-21.
Krause DS. Economic effectiveness of disease management programs: a meta-analysis. Dis Manag. 2005;8(2):114-34.
Boland MR, Tsiachristas A, Kruis AL, Chavannes NH, Rutten-van Mölken MP. The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis. BMC Pulm Med. 2013;13:40.
Kirsch F. A Systematic Review Of Markov Models Evaluating Multi-Component Disease Management Programs. Value Health. 2015;18(7):A502.
Arora R, Boehm J, Chimento L, Moldawer L, Tsien C. Designing and Implementing Medicaid Disease and Care Management Programs: A User’s Guide. Rockville: Agency for Healthcare Research and Quality; 2008.
Lemmens K, Nieboer A, Van Schayck C, Asin J, Huijsman R. A model to evaluate quality and effectiveness of disease management. Qual Saf Health Care. 2008;17(6):447-53.
Mattke S, Seid M, Ma S. Evidence for the effect of disease management: is $1 billion a year a good investment? A J Manag Care. 2007;13(12):670.
MacStravic S. Therapeutic Specificity in Disease Management Evaluation. Dis Manag. 2008;11(1):7-11.
Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. 2004;39(4p1):1005-26.
Stock SAK, Redaelli M, Lauterbach KW. Disease management and health care reforms in Germany-does more competition lead to less solidarity? Health Policy. 2007;80(1):86-96.
Gazmararian JA, Williams MV, Peel J, Baker DW. Health literacy and knowledge of chronic disease. Patient Educ Couns. 2003;51(3):267-75.
Hunter DJ, Fairfield G. Disease management. BMJ. 1997;315(7099):50-3.
Bayerstadler A, Benstetter F, Heumann C, Winter F. A predictive modeling approach to increasing the economic effectiveness of disease management programs. Health Care Manag Sci. 2014;17(3):284-301.
Verbeek NA, Franken M, Tsiachristas A, Koopmanschap MA, Rutten-van Mölken MP. A Triple Aim Framework For The Performance Assessment Of Disease Management Programs. Value Health. 2015;18(7):A400.
Wang L, Kuntz-Melcavage K, Forrest CB, Lu Y, Piet L, Evans K, et al. Development and applications of an outcomes assessment framework for care management programs in learning health systems. EGEMS (Wash DC). 2015;3(1):1119.
Licencia
Derechos de autor 2017 Revista de la Facultad de Medicina
Esta obra está bajo una licencia Creative Commons Reconocimiento 3.0 Unported.
-
